ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TLRY vs JNJ // OPERATING MARGIN

Tilray Brands Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: TLRY 1 — JNJ 9
▲ OPERATING MARGIN LEADER: JNJ
operating-margins
-6.90%
operating-margins
34.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLRY VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TLRY JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 28.40% 67.90% -39.50 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) -3.90% 25.50% -29.40 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -17.72% 2.97% -20.69 JNJ /fcf-yield <GO>
Operating Margin ACTIVE -6.90% 34.70% -41.60 JNJ /operating-margins <GO>
Net Profit Margin -13.30% 28.50% -41.80 JNJ /net-margins <GO>
Revenue Growth (YoY) 11.50% 6.00% +5.50 TLRY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 5.59 -5.39 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 18.4 62.1 -43.67 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $390.2M $662.49B -$662.10B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TLRY REV JNJ REV TLRY GROSS % JNJ GROSS % TLRY FCF JNJ FCF
FY 2025 $915.5M $94.19B 28.4% 67.9% -$69.1M $19.70B
FY 2024 $821.3M $88.82B 29.3% 69.1% -$94.6M $19.84B
FY 2023 $788.9M $85.16B — — -$30.9M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLRY // BETA —
JNJ // BETA 1.08